2m 2m 2m 2m 2m 2m 2m
ELECTROCORE (ECOR)
NASDAQ
$8.36+$0.005 (+0.06%)
Price as of Jun 23, 2026 4:24 PM EDT- $67.4MMarket Cap
- 54.34%1-Year Change
- Medical DevicesIndustry
ELECTROCORE (ECOR)
$8.36+$0.005 (+0.06%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 32.0M +27.20% | 25.2M +57.09% | 16.0M +86.57% | 8.6M +57.62% | |
Cost of Revenue | 4.2M +12.13% | 3.8M +34.99% | 2.8M +73.51% | 1.6M +16.68% | |
Gross Profit | 27.8M +29.87% | 21.4M +61.78% | 13.2M +89.59% | 7.0M +71.56% | |
Sales and Marketing Expense | 38.2M +22.46% | 31.2M +14.81% | 27.2M +11.69% | 24.3M +12.78% | |
Research and Development Expense | -2.7M +15.89% | -2.4M -55.65% | -5.3M -196.39% | 5.5M +117.68% | |
Depreciation and Amortization Expense | 501,000 -34.08% | 760,000 -21.00% | 962,000 +75.55% | 548,000 +43.64% | |
Total Operating Expenses | 40.9M +22.00% | 33.6M +3.27% | 32.5M +8.86% | 29.9M +23.81% | |
Operating Profit | -13.2M +8.15% | -12.2M -36.88% | -19.3M -15.76% | -22.9M +14.12% | |
Interest Income | 298,000 -47.90% | 572,000 +32.10% | 433,000 +50.87% | 287,000 +2,587.77% | |
Interest Expense | -14,900 -19.02% | -18,400 +50.82% | -12,200 +205.00% | -4,000 -24.41% | |
Interest Income and Expense and Net | 283,100 -48.86% | 553,600 +31.56% | 420,800 +46.62% | 287,000 +2,587.77% | |
Total Nonoperating Income and Expense | -810,000 -542.62% | 183,000 -26.51% | 249,000 -11.39% | 281,000 -85.76% | |
Income before Taxes | -14.0M +16.56% | -12.0M -37.02% | -19.0M -15.81% | -22.6M +25.04% | |
Income Taxes | 3,000 +103.23% | -93,000 -50.00% | -186,000 -56.84% | -431,000 -49.36% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -14.0M +17.63% | -11.9M -36.89% | -18.8M -15.02% | -22.2M +28.71% | |
Net Income from Continuing Operations Applicable to Common | -14.0M +16.56% | -12.0M -36.40% | -18.8M -15.02% | -22.2M +22.65% | |
Basic EPS and Net Income | -1.65 +3.77% | -1.59 -53.51% | -3.42 -27.08% | -4.69 +1,517.24% | |
Diluted EPS and Net Income | -1.65 +3.77% | -1.59 -53.51% | -3.42 -27.08% | -4.69 +1,517.24% | |
Basic Weighted Average Shares | 8,483 -99.89% | 7.5M +135,584.50% | 5,515 +16.62% | 4,729 -99.99% | |
Diluted Weighted Average Shares | 8,483 -99.89% | 7.5M +135,584.50% | 5,515 +16.62% | 4,729 -99.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.0M +103.91% | 3.5M -66.61% | 10.3M -41.67% | 17.7M -48.94% | |
Short-Term Investments | 4.6M -46.00% | 8.5M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 11.6M -2.79% | 12.0M +15.86% | 10.3M -41.67% | 17.7M -48.94% | |
Total Current Assets | 15.7M -3.89% | 16.3M +14.03% | 14.3M -32.49% | 21.2M -43.60% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 382,000 +141.77% | 158,000 -22.55% | 204,000 +308.00% | 50,000 -65.89% | |
Total Long-Term Assets | 54,000 -80.29% | 274,000 -44.65% | 495,000 -36.05% | 774,000 +30.85% | |
Total Assets | 18.7M -8.81% | 20.5M +27.13% | 16.1M -34.96% | 24.8M -42.20% | |
Income Taxes Payable | 524,000 +37.17% | 382,000 +40.44% | 272,000 -4.56% | 285,000 N/A | |
Total Short-Term Debt | N/A N/A | 205,000 -17.00% | 247,000 -6.44% | 264,000 -47.11% | |
Total Current Liabilities | 11.3M +23.99% | 9.2M +12.67% | 8.1M +15.30% | 7.0M +28.43% | |
Total Long-Term Debt | 6.6M N/A | N/A N/A | N/A N/A | 1.5M +1,092.23% | |
Total Long-Term Liabilities | 9.0M +139.15% | 3.8M +602.98% | 537,000 -14.08% | 625,000 -10.65% | |
Total Liabilities | 20.4M +57.62% | 12.9M +49.27% | 8.7M +12.91% | 7.7M +24.01% | |
Retained Earnings | -191.1M +7.89% | -177.1M +7.19% | -165.2M +12.87% | -146.4M +17.84% | |
Total Stockholders Equity | -1.7M -122.65% | 7.5M +1.37% | 7.4M -56.44% | 17.1M -53.38% | |
Total Shares Outstanding | 8.0M +20.35% | 6.7M +10.80% | 6.0M +26.51% | 4.7M -93.29% | |
Cash Flow | |||||
Cash from Operating Activities | -8.2M +17.83% | -6.9M -52.63% | -14.7M -11.88% | -16.6M +22.14% | |
Capital Expenditures | 66,000 N/A | N/A N/A | 206,000 N/A | N/A N/A | |
Cash from Investing Activities | 3.9M +145.51% | -8.5M +4,035.44% | -206,000 N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.6M -9.62% | 8.4M +12.72% | 7.5M N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | 86.75% +2.10% | 84.97% +2.98% | 82.51% +1.62% | 81.19% +8.85% | |
Operating Margin | -41.06% -14.98% | -48.30% -59.82% | -120.21% -54.85% | -266.22% -27.59% | |
Return on Assets | -71.44% +9.92% | -65.00% -29.50% | -92.19% +40.58% | -65.58% +41.59% | |
Return on Equity | -479.21% +202.10% | -158.63% +3.29% | -153.57% +86.17% | -82.49% +42.90% | |
Revenue Growth | 27.20% -52.35% | 57.09% -34.05% | 86.57% +50.25% | 57.62% +3.01% | |
Current Ratio | 1.38 -22.49% | 1.78 +1.21% | 1.76 -41.45% | 3.01 -56.09% | |
Cash Ratio | 0.62 +64.43% | 0.38 -70.36% | 1.27 -49.41% | 2.51 -60.24% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.10 +502.94% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.07 +384.93% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow